Modified-Release Minoxidil Compositions and Methods for Hair Loss Treatment
Summary
The USPTO published patent application US20260097035A1 filed by inventor Reid Waldman on December 10, 2025, covering modified-release minoxidil compositions for treating hair loss. The application discloses pharmaceutical formulations for oral administration of modified-release minoxidil and methods of using the compositions for hair loss treatment.
What changed
The USPTO published a patent application covering modified-release minoxidil pharmaceutical formulations for oral administration and methods of treating hair loss. The application discloses compositions including slow modified-release vehicles containing minoxidil or a pharmaceutically acceptable salt, potentially combined with additional active agents.
For pharmaceutical companies and investors, this published application provides visibility into potential future competition in the modified-release minoxidil hair loss treatment space. The application represents early-stage intellectual property that does not yet confer any exclusive rights or create compliance obligations until the patent grants.
What to do next
- Monitor for updates on patent prosecution status
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
Application US20260097035A1 Kind: A1 Apr 09, 2026
Inventors
Reid WALDMAN
Abstract
The compositions and methods provided herein include a pharmaceutical formulation for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Also provided herein are pharmaceutical formulations for oral administration comprising a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof and one or more additional active agents. Also provided herein are methods of treating hair loss by administering to a subject in need thereof a daily dose of a modified release formulation of minoxidil or a pharmaceutically acceptable salt thereof. Further provided herein is a kit including a slow modified release vehicle comprising oral minoxidil or a pharmaceutically acceptable salt thereof.
CPC Classifications
A61K 31/506 A61K 9/0053 A61K 9/2013 A61K 9/2018 A61K 9/2054 A61K 9/28 A61P 17/14
Filing Date
2025-12-10
Application No.
19415540
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.